Table 1.
Patient baseline characteristics.
| Hip OA (n = 192) |
Knee OA (n = 380) |
|
|---|---|---|
| Female | 128 (66.7%) | 267 (70.3%) |
| Age (years) | 61.5 [56.5–68.0] | 61.0 [55.0–69.0] |
| BMI (kg/m2) | 26.3 [24.3–29.4] | 28.8 [25.7–32.7] |
| Groll comorbidity index | 2.0 [1.0–3.0] | 2.0 [1.0–3.0] |
| Smokers | 30 (15.6%) | 53 (14.1%) |
| Still’s disease | 6 (3.1%) | 14 (3.7%) |
| Normalized Pain VAS (0–100) | 30.0 [20.0–45.0] | 30.0 [15.0–40.0] |
| Normalized function (0–100) | 31.3 [14.8–49.8] | 28.7 [13.1–45.9] |
| Kellgren and Lawrence score | ||
| 2 | 133 (69.3%) | 233 (61.3%) |
| 3 | 59 (30.7%) | 147 (38.7%) |
| Oxytocin (pg/mL) | 3.0 [1.8–7.2] | 3.1 [1.6–6.7] |
| Adiponectin (μg/mL) | 5.6 [3.9–8.0] | 5.8 [4.0–8.2] |
| Leptin (ng/mL) | 12.8 [6.4–27.8] | 22.0 [9.2–44.6] |
| Estradiol (pg/mL) | 11.5 [11.0–21.6] | 12.4 [11.0–21.8] |
Data are presented as the median [Q1; Q3] or number (%). BMI: Body Mass Index; OA: osteoarthritis; VAS: Visual Analogical Scale.